Innovations in therapies for heart valve disease

Circulation Journal

Volumn 75, Issue 5, 2011, Pages 1028-1041

  Padala, Muralidhar ^a   Keeling, William Brent ^a   Guyton, Robert A ^a   Thourani, Vinod H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Annuloplasty rings; Heart valve; Minimally invasive valve repair; Replacement valves; Transcatheter valve repair

Indexed keywords

ANNULOPLASTY; AORTA STENOSIS; AORTA VALVE PROSTHESIS; BIODEGRADABLE IMPLANT; BIOMECHANICS; BIOMEDICAL TECHNOLOGY ASSESSMENT; BRACHIAL PLEXUS INJURY; BYPASS SURGERY; CLINICAL PRACTICE; EQUIPMENT DESIGN; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HUMAN; MITRAL VALVE PROSTHESIS; MITRAL VALVE REGURGITATION; NONHUMAN; PARESTHESIA; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS FAILURE; REVIEW; STENTLESS AORTIC BIOPROSTHESIS; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SUTURELESS AORTIC VALVE PROSTHESIS; TRANSCATHETER AORTIC VALVE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSCATHETER MITRAL ANNULOPLASTY; VALVULAR HEART DISEASE;

ANIMALS; EQUIPMENT AND SUPPLIES; HEART VALVE DISEASES; HUMANS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TECHNOLOGY, MEDICAL;

EID: 79955681805     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0289     Document Type: Review

References (88)

1. Shipton B, Wahba H. Valvular heart disease: Review and update. Am Fam Physician 2001; 63: 2201-2208.
2. Craver JM, Weintraub WS, Jones EL, Guyton RA, Hatcher CR Jr. Predictors of mortality, complications, and length of stay in aortic valve replacement for aortic stenosis. Circulation 1988; 78: I85-I90.
3. David TE. Aortic valve replacement with stentless porcine bioprostheses. J Card Surg 1998; 13: 344-351.
4. Gillinov AM, Blackstone EH, Nowicki ER, Slisatkorn W, Al-Dossari G, Johnston DR, et al. Valve repair versus valve replacement for degenerative mitral valve disease. J Thorac Cardiovasc Surg 2008; 135: 885-893, 893.e1-e2.
5. McCarthy PM, Bhudia SK, Rajeswaran J, Hoercher KJ, Lytle BW, Cosgrove DM, et al. Tricuspid valve repair: Durability and risk factors for failure. J Thorac Cardiovasc Surg 2004; 127: 674-685.
6. Lindroos M, Kupari M, Heikkilä J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: An echocardiographic study of a random population sample. J Am Coll Cardiol 1993; 21: 1220-1225.
7. Samanek M, Slavík Z, Zborilová B, Hrobonová V, Vorísková M, Skovránek J. Prevalence, treatment, and outcome of heart disease in live-born children: A prospective analysis of 91,823 live-born children. Pediatr Cardiol 1989; 10: 205-211.
8. Haller JA Jr, Morrow AG, Roshe J. Combined aortic and mitral insufficiency-Hemodynamic effects of the Hufnagel valve. Ann Surg 1956; 144: 854-860.
9. Cooley DA, Morris GC Jr, Moyer JH. The effects of the Hufnagel valve on renal hemodynamics in subjects with aortic valvular insufficiency. Surg Forum 1956; 6: 237-241.
10. Dasi LP, Simon HA, Sucosky P, Yoganathan AP. Fluid mechanics of artificial heart valves. Clin Exp Pharmacol Physiol 2009; 36: 225-237.
11. Yoganathan AP, He Z, Casey Jones S. Fluid mechanics of heart valves. Ann Rev Biomed Eng 2004; 6: 331-362.
12. Tossios P, Reber D, Oustria M, Holland-Letz T, Germing A, Buchwald D, et al. Single-center experience with the On-X prosthetic heart valve between 1996 and 2005. J Heart Valve Dis 2007; 16: 551-557.
13. Ikonomidis JS, Kratz JM, Crumbley AJ 3rd, Stroud MR, Bradley SM, Sade RM, et al. Twenty-year experience with the St Jude Medical mechanical valve prosthesis. J Thorac Cardiovasc Surg 2003; 126: 2022-2031.
14. Azarnoush K, Laborde F, de Riberolles C. The Sorin Bicarbon over 15 years clinical outcomes: Multicentre experience in 1704 patients. Eur J Cardiothorac Surg 2010; 38: 759-766.
15. Baykut D, Grize L, Schindler C, Keil AS, Bernet F, Zerkowski HR. Eleven-year single-center experience with the ATS Open Pivot Bileaflet heart valve. Ann Thorac Surg 2006; 82: 847-852.
16. Dasi LP, Murphy DW, Glezer A, Yoganathan AP. Passive flow control of bileaflet mechanical heart valve leakage flow. J Biomech 2008; 41: 1166-1173.
17. Murphy DW, Dasi LP, Vukasinovic J, Glezer A, Yoganathan AP. Reduction of procoagulant potential of b-datum leakage jet flow in bileaflet mechanical heart valves via application of vortex generator arrays. J Biomech Eng 2010; 132: 071011.
18. McKellar SH, Thompson JL 3rd, Garcia-Rinaldi RF, Macdonald RJ, Sundt TM 3rd, Schaff HV. Short- and long-term efficacy of aspirin and clopidogrel for thromboprophylaxis for mechanical heart valves: An in vivo study in swine. J Thorac Cardiovasc Surg 2008; 136: 908-914.
19. Carpentier A. From valvular xenograft to valvular bioprosthesis (1965-1977). Med Instrum 1977; 11: 98-101.
20. Carpentier A. The concept of bioprosthesis. Thoraxchir Vask Chir 1971; 19: 379-383.
21. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: Progress toward understanding and prevention. Ann Thorac Surg 2005; 79: 1072-1080.
22. Rapoport HS, Connolly JM, Fulmer J, Dai N, Murti BH, Gorman RC, et al. Mechanisms of the in vivo inhibition of calcification of bioprosthetic porcine aortic valve cusps and aortic wall with triglycidylamine/ mercapto bisphosphonate. Biomaterials 2007; 28: 690-699.
23. Webb CL, Schoen FJ, Flowers WE, Alfrey AC, Horton C, Levy RJ. Inhibition of mineralization of glutaraldehyde-pretreated bovine pericardium by AlCl3. Mechanisms and comparisons with FeCl3, LaCl3, and Ga(NO3)3 in rat subdermal model studies. Am J Pathol 1991; 138: 971-981.
24. Girardot MN, Torrianni M, Girardot JM. Effect of AOA on glutaraldehyde- fixed bioprosthetic heart valve cusps and walls: Binding and calcification studies. Int J Artif Organs 1994; 17: 76-82.
25. Hirsch D, Drader J, Thomas TJ, Schoen FJ, Levy JT, Levy RJ. Inhibition of calcification of glutaraldehyde pretreated porcine aortic valve cusps with sodium dodecyl sulfate: Preincubation and controlled release studies. J Biomed Mater Res 1993; 27: 1477-1484.
26. Vyavahare N, Hirsch D, Lerner E, Baskin JZ, Schoen FJ, Bianco R, et al. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation 1997; 95: 479-488.
27. Gao ZB, Pandya S, Hosein N, Sacks MS, Hwang NH. Bioprosthetic heart valve leaflet motion monitored by dual camera stereo photogrammetry. J Biomech 2000; 33: 199-207.
28. David TE, Ropchan GC, Butany JW. Aortic valve replacement with stentless porcine bioprostheses. J Card Surg 1988; 3: 501-505.
29. Walther T, Falk V, Diegeler A, Gummert J, Autschbach R, Mohr FW. Stentless valve replacement in the small aortic root. Cardiovasc Surg 1997; 5: 229-234.
30. Bach DS, Kon ND, Dumesnil JG, Sintek CF, Doty DB. Eight-year results after aortic valve replacement with the Freestyle stentless bioprosthesis. J Thorac Cardiovasc Surg 2004; 127: 1657-1663.
31. Bach DS, Metras J, Doty JR, Yun KL, Dumesnil JG, Kon ND. Freedom from structural valve deterioration among patients aged < or = 60 years undergoing Freestyle stentless aortic valve replacement. J Heart Valve Dis 2007; 16: 649-655; discussion 656.
32. Ennker JA, Ennker IC, Albert AA, Rosendahl UP, Bauer S, Florath I. The Freestyle stentless bioprosthesis in more than 1000 patients: A single-center experience over 10 years. J Card Surg 2009; 24: 41-48.
33. Pavoni D, Badano LP, Ius F, Mazzaro E, Frassani R, Gelsomino S, et al. Limited long-term durability of the Cryolife O'Brien stentless porcine xenograft valve. Circulation 2007; 116(11 Suppl): I307-I313.
34. Chan KM, Rahman-Haley S, Mittal TK, Gavino JA, Dreyfus GD. Truly stentless autologous pericardial aortic valve replacement: An alternative to standard aortic valve replacement. J Thorac Cardiovasc Surg 2011; 141: 276-283.
35. Pillai R, Ratnatunga C, Soon JL, Kattach H, Khalil A, Jin XY. 3f prosthesis aortic cusp replacement: Implantation technique and early results. Asian Cardiovasc Thorac Ann 2010; 18: 13-16.
36. Martens S, Ploss A, Sirat S, Miskovic A, Moritz A, Doss M. Sutureless aortic valve replacement with the 3f Enable aortic bioprosthesis. Ann Thorac Surg 2009; 87: 1914-1917.
37. Shrestha M, Folliguet T, Meuris B, Dibie A, Bara C, Herregods MC, et al. Sutureless Perceval S aortic valve replacement: A multicenter, prospective pilot trial. J Heart Valve Dis 2009; 18: 698-702.
38. Hara H, Schwartz RS. Transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis. Circ J 2010; 74: 1513-1517.
39. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation 2002; 106: 3006-3008.
40. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010; 122: 62-69.
41. Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, et al. Percutaneous implantation of the Core Valve self-expanding valve prosthesis in high-risk patients with aortic valve disease: The Siegburg first-in-man study. Circulation 2006; 114: 1616-1624.
42. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607.
43. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: Results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008; 4: 242-249.
44. Dewey TM, Walther T, Doss M, Brown D, Ryan WH, Svensson L, et al. Transapical aortic valve implantation: An animal feasibility study. Ann Thorac Surg 2006; 82: 110-116.
45. Ye J, Cheung A, Lichtenstein SV, Nietlispach F, Albugami S, Masson JB, et al. Transapical transcatheter aortic valve implantation: Follow-up to 3 years. J Thorac Cardiovasc Surg 2010; 139: 1107-1113, 1113.e1.
46. Modine T, Obadia JF, Choukroun E, Rioufoul G, Sudre A, Laborde JC, et al. Transcutaneous aortic valve implantation using the axillary/ subclavian access: Feasibility and early clinical outcomes. J Thorac Cardiovasc Surg 2011; 141: 487-491.
47. Gammie JS, Krowsoski LS, Brown JM, Odonkor PN, Young CA, Santos MJ, et al. Aortic valve bypass surgery: Midterm clinical outcomes in a high-risk aortic stenosis population. Circulation 2008; 118: 1460-1466.
48. Vassiliades TA Jr. Off-pump apicoaortic conduit insertion for highrisk patients with aortic stenosis. Eur J Cardiothorac Surg 2003; 23: 156-158.
49. Thourani VH, Keeling WB, Guyton RA, Dara A, Hurst SD, Lattouf OM. Outcomes of off-pump aortic valve bypass surgery for the relief of aortic stenosis in adults. Ann Thorac Surg 2011; 91: 131-136.
50. Wang Q, McGoron AJ, Pinchuk L, Schoephoerster RT. A novel small animal model for biocompatibility assessment of polymeric materials for use in prosthetic heart valves. J Biomed Mater Res A 2010; 93: 442-453.
51. Ghanbari H, Viatge H, Kidane AG, Burriesci G, Tavakoli M, Seifalian AM. Polymeric heart valves: New materials, emerging hopes. Trends Biotechnol 2009; 27: 359-367.
52. Schmidt D, Stock UA, Hoerstrup SP. Tissue engineering of heart valves using decellularized xenogeneic or polymeric starter matrices. Philos Trans R Soc Lond B Biol Sci 2007; 362: 1505-1512.
53. Leo HL, Dasi LP, Carberry J, Simon HA, Yoganathan AP. Fluid dynamic assessment of three polymeric heart valves using particle image velocimetry. Ann Biomed Eng 2006; 34: 936-952.
54. Leo HL, Simon H, Carberry J, Lee SC, Yoganathan AP. A comparison of flow field structures of two tri-leaflet polymeric heart valves. Ann Biomed Eng 2005; 33: 429-443.
55. Padala M, Hutchison RA, Croft LR, Jimenez JH, Gorman RC, Gorman JH 3rd, et al. Saddle shape of the mitral annulus reduces systolic strains on the P2 segment of the posterior mitral leaflet. Annals Thorac Surg 2009; 88: 1499-1504.
56. Jimenez JH, Liou SW, Padala M, He Z, Sacks M, Gorman RC, et al. A saddle-shaped annulus reduces systolic strain on the central region of the mitral valve anterior leaflet. J Thorac Cardiovasc Surg 2007; 134: 1562-1568.
57. Jensen MO, Jensen H, Smerup M, Levine RA, Yoganathan AP, Nygaard H, et al. Saddle-shaped mitral valve annuloplasty rings experience lower forces compared with flat rings. Circulation 2008; 118(14 Suppl): S250-S255.
58. Jimenez JH, Soerensen DD, He Z, He S, Yoganathan AP. Effects of a saddle shaped annulus on mitral valve function and chordal force distribution: An in vitro study. Ann Biomed Eng 2003; 31: 1171-1181.
59. Jensen MO, Jensen H, Levine RA, Yoganathan AP, Andersen NT, Nygaard H, et al. Saddle-shaped mitral valve annuloplasty rings improve leaflet coaptation geometry. J Thorac Cardiovasc Surg 2011 Feb 15 [Epub ahead of print].
60. Mack MJ. Coronary sinus in the management of functional mitral regurgitation: The mother lode or fool's gold? Circulation 2006; 114: 363-364.
61. Webb JG, Harnek J, Munt BI, Kimblad PO, Chandavimol M, Thompson CR, et al. Percutaneous transvenous mitral annuloplasty: Initial human experience with device implantation in the coronary sinus. Circulation 2006; 113: 851-855.
62. Van Mieghem NM, Piazza N, Anderson RH, Tzikas A, Nieman K, De Laat LE, et al. Anatomy of the mitral valvular complex and its implications for transcatheter interventions for mitral regurgitation. J Am Coll Cardiol 2010; 56: 617-626.
63. Tops LF, Van de Veire NR, Schuijf JD, de Roos A, van der Wall EE, Schalij MJ, et al. Noninvasive evaluation of coronary sinus anatomy and its relation to the mitral valve annulus: Implications for percutaneous mitral annuloplasty. Circulation 2007; 115: 1426-1432.
64. Choure AJ, Garcia MJ, Hesse B, Sevensma M, Maly G, Greenberg NL, et al. In vivo analysis of the anatomical relationship of coronary sinus to mitral annulus and left circumflex coronary artery using cardiac multidetector computed tomography: Implications for percutaneous coronary sinus mitral annuloplasty. J Am Coll Cardiol 2006; 48: 1938-1945.
65. Maselli D, Guarracino F, Chiaramonti F, Mangia F, Borelli G, Minzioni G. Percutaneous mitral annuloplasty: An anatomic study of human coronary sinus and its relation with mitral valve annulus and coronary arteries. Circulation 2006; 114: 377-380.
66. Plass A, Valenta I, Gaemperli O, Kaufmann P, Alkadhi H, Zund G, et al. Assessment of coronary sinus anatomy between normal and insufficient mitral valves by multi-slice computertomography for mitral annuloplasty device implantation. Eur J Cardiothorac Surg 2008; 33: 583-589.
67. Maisano F, Torracca L, Oppizzi M, Stefano PL, D'Addario G, La Canna G, et al. The edge-to-edge technique: A simplified method to correct mitral insufficiency. Eur J Cardiothorac Surg 1998; 13: 240-245.
68. Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R, et al. Percutaneous mitral repair with the MitraClip system: Safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) Cohort. J Am Coll Cardiol 2009; 54: 686-694.
69. Mauri L, Garg P, Massaro JM, Foster E, Glower D, Mehoudar P, et al. The EVEREST II Trial: Design and rationale for a randomized study of the evalve mitraclip system compared with mitral valve surgery for mitral regurgitation. Am Heart J 2010; 160: 23-29.
70. Padala M, Powell SN, Croft LR, Thourani VH, Yoganathan AP, Adams DH. Mitral valve hemodynamics after repair of acute posterior leaflet prolapse: Quadrangular resection versus triangular resection versus neochordoplasty. J Thorac Cardiovasc Surg 2009; 138: 309-315.
71. Falk V, Seeburger J, Czesla M, Borger MA, Willige J, Kuntze T, et al. How does the use of polytetrafluoroethylene neochordae for posterior mitral valve prolapse (loop technique) compare with leaflet resection? A prospective randomized trial. J Thorac Cardiovasc Surg 2008; 136: 1205; discussion 1205-1206.
72. Perier P, Hohenberger W, Lakew F, Batz G, Urbanski P, Zacher M, et al. Toward a new paradigm for the reconstruction of posterior leaflet prolapse: Midterm results of the "respect rather than resect" approach. Ann Thorac Surg 2008; 86: 718-725; discussion 718-725.
73. Fukamachi K, Inoue M, Popović ZB, Doi K, Schenk S, Nemeh H, et al. Off-pump mitral valve repair using the Coapsys device: A pilot study in a pacing-induced mitral regurgitation model. Ann Thorac Surg 2004; 77: 688-692.
74. Fukamachi K, Inoue M, Popovi ZB, Kazuyoshi D, Schenk S, Nemeh H, et al. Off-pump mitral valve repair using the Coapsys device: A pilot study in a pacing-induced mitral regurgitation model. Ann Thorac Surg 2004; 77: 688-692.
75. Sundt TM. Off-pump mitral valve repair using the coapsys device: A pilot study in a pacing-induced mitral regurgitation model-Discussion-Invited commentary. Ann Thorac Surg 2004; 77: 693.
76. Inoue M, McCarthy PM, Popovic ZB, Doi K, Schenk S, Nemeh H, et al. The Coapsys device to treat functional mitral regurgitation: In vivo chronic canine study. J Thorac Cardiovasc Surg 2004; 127: 1068-1077.
77. Inoue M, McCarthy PM, Popović ZB, Doi K, Schenk S, Nemeh H, et al. The Coapsys device to treat functional mitral regurgitation: In vivo long-term canine study. J Thorac Cardiovasc Surg 2004; 127: 1068-1077.
78. Mishra YK, Mittal S, Jaguri P, Trehan N. Coapsys mitral annuloplasty for chronic functional ischemic mitral regurgitation: 1-year results. Ann Thorac Surg 2006; 81: 42-46.
79. Grossi EA, Patel N, Woo YJ, Goldberg JD, Schwartz CF, Subramanian V, et al. Outcomes of the RESTOR-MV Trial (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve). J Am Coll Cardiol 2010; 56: 1984-1993.
80. Ma L, Tozzi P, Huber CH, Taub S, Gerelle G, von Segesser LK. Double-crowned valved stents for off-pump mitral valve replacement. Eur J Cardiothorac Surg 2005; 28: 194-198.
81. [Anon]. Double-crowned valved stents for off-pump mitral valve replacement-Appendix A: Conference discussion. Eur J Cardiothorac Surg 2005; 28: 198.
82. Lutter G, Quaden R, Osaki S, Hu J, Renner J, Edwards NM, et al. Off-pump transapical mitral valve replacement. Eur J Cardiothorac Surg 2009; 36: 124-128.
83. Lozonschi L, Bombien R, Osaki S, Hu J, Snell D, Edwards NM, et al. Transapical mitral valved stent implantation: A survival series in swine. J Thorac Cardiovasc Surg 2010; 140: 422-426.e1.
84. Boudjemline Y, Agnoletti G, Bonnet D, Behr L, Borenstein N, Sidi D, et al. Steps toward the percutaneous replacement of atrioventricular valves an experimental study. J Am Coll Cardiol 2005; 46: 360-365.
85. Bonhoeffer P, Boudjemline Y, Saliba Z, Hausse AO, Aggoun Y, Bonnet D, et al. Transcatheter implantation of a bovine valve in pulmonary position: A lamb study. Circulation 2000; 102: 813-816.
86. Lurz P, Coats L, Khambadkone S, Nordmeyer J, Boudjemline Y, Schievano S, et al. Percutaneous pulmonary valve implantation: Impact of evolving technology and learning curve on clinical outcome. Circulation 2008; 117: 1964-1972.
87. Miyazaki A, Yamamoto M, Sakaguchi H, Tsukano S, Kagisaki K, Suyama K, et al. Pulmonary valve replacement in adult patients with a severely dilated right ventricle and refractory arrhythmias after repair of tetralogy of fallot. Circ J 2009; 73: 2135-2142.
88. Cubeddu RJ, Hijazi ZM. Bailout perventricular pulmonary valve implantation following failed percutaneous attempt using the Edwards Sapien transcatheter heart valve. Catheterization Cardiovasc Interv 2011; 77: 276-280.